HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Companies

Endo Appoints New CMO

This article was originally published in Scrip

Endo International Plc has named Craig Paterson chief medical officer. Paterson will be responsible for the company's global clinical development strategies and lifecycle management. Before joining Endo, Paterson was senior vice-president of medical and clinical development for Salix Pharmaceuticals and he has held roles within medical and clinical development at GlaxoSmithKline plc and King Pharmaceuticals, a wholly owned subsidiary of Pfizer Inc.

Table

View full table

Topics

Related Companies

Tags:
Companies
Latest Headlines

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation

Probiotics And Cold Remedies Boost Recordati In 2023

See All
UsernamePublicRestriction

Register

SC029727

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By